Patent directory · USPTO A61K / A61P
Patents matching “Northwestern University”
565 pharma patents match "Northwestern University" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 565 pharmaceutical patents matching "Northwestern University" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9585975
MRI contrast agents
granted -
US 9586890
Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods
granted -
US 9580400
Cannabinergic nitrate esters and related analogs
granted -
US 9572910
pH responsive self-healing hydrogels formed by boronate-catechol complexation
granted -
US 9566355
Bacteria-targeted magnetic resonance contrast agents
granted -
US 9556232
Anti-angiogenic molecules, nanostructures and uses thereof
granted -
US 9533947
Benzamide compounds and related methods of use
granted -
US 9532948
Nanostructure suitable for sequestering cholesterol and other molecules
granted -
US 9527819
Pyridazine compounds, compositions and methods
granted -
US 9522180
Peptide conjugated particles
granted -
US 9517275
Targeted therapy for the prevention of restenosis in the cardiovascular system
granted -
US 9517233
Local cochlear application of statins for stimulating neurite regrowth in the cochlea
granted -
US 9512133
NMDA receptor modulators and uses thereof
granted -
US 9506056
Nucleic acid functionalized nanoparticles for therapeutic applications
granted -
US 9499494
Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
granted -
US 9486540
Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
granted -
US 9474716
SiRNA phospholipid conjugate
granted -
US 9463186
Treatment for dopaminergic disorders
granted -
US 9428467
Selective calcium channel antagonists
granted -
US 9408845
Formulations containing pyridazine compounds
granted -
US 9376690
Templated nanoconjugates
granted -
US 9371277
Benzamide compounds and related methods of use
granted -
US 9340792
Recombinant Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses
granted -
US 9340576
Methods of treating depression and other related diseases
granted